Dr. Ken Dutton-Regester completed his PhD in 2012 at the Queensland Institute of Medical Research (QIMR) through the Queensland University of Technology (QUT) under the supervision of Professor Nick Hayward (QIMR). During his PhD, Ken was funded by an Australian Postgraduate Award, QUT, QIMR and a Queensland government Smart Futures scholarship. His thesis focused on the genetics of melanoma, specifically, identifying the mutations driving the development and progression of sporadic melanoma. Through use of high throughput technologies, including next-generation sequencing, Ken and the Oncogenomics laboratory have identified a number of new genes involved in melanomagenesis including TFG, MAP3K5 and MAP3K9. His current focus involves the investigation of melanomas with an unknown primary, of which, is funded by a grant he received from the Rio Tinto Ride to Conquer Cancer fund.
Abstracts this author is presenting: